Cargando…
Small molecule inhibitor CRT0066101 inhibits cytokine storm syndrome in a mouse model of lung injury
Pneumonia is an acute inflammation of the lungs induced by pathogenic microorganisms, immune damage, physical and chemical factors, and other factors, and the latest outbreak of novel coronavirus pneumonia is also an acute lung injury (ALI) induced by viral infection. However, there are currently no...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181585/ https://www.ncbi.nlm.nih.gov/pubmed/37182445 http://dx.doi.org/10.1016/j.intimp.2023.110240 |
_version_ | 1785041609334718464 |
---|---|
author | Cui, Bomiao Liu, Yiying Chen, Jiao Chen, Hongli Feng, Yun Zhang, Ping |
author_facet | Cui, Bomiao Liu, Yiying Chen, Jiao Chen, Hongli Feng, Yun Zhang, Ping |
author_sort | Cui, Bomiao |
collection | PubMed |
description | Pneumonia is an acute inflammation of the lungs induced by pathogenic microorganisms, immune damage, physical and chemical factors, and other factors, and the latest outbreak of novel coronavirus pneumonia is also an acute lung injury (ALI) induced by viral infection. However, there are currently no effective treatments for inflammatory cytokine storms in patients with ALI/acute respiratory distress syndrome (ARDS). Protein kinase D (PKD) is a highly active kinase that has been shown to be associated with the production of inflammatory cytokines. Therefore, small-molecule compounds that inhibit PKD may be potential drugs for the treatment of ALI/ARDS. In the present study, we evaluated the ability of the small-molecule inhibitor CRT0066101 to attenuate lipopolysaccharide (LPS)-induced inflammatory cytokine production through in vitro cell experiments and a mouse pneumonia model. We found that CRT0066101 significantly reduced the protein and mRNA levels of LPS-induced cytokines (e.g., IL-6, TNF-α, and IL-1β). CRT0066101 inhibited MyD88 and TLR4 expression and reduced NF-κB, ERK, and JNK phosphorylation. CRT0066101 also reduced NLRP3 activation, inhibited the assembly of the inflammasome complex, and attenuated inflammatory cell infiltration and lung tissue damage. Taken together, our data indicate that CRT0066101 exerts anti-inflammatory effects on LPS-induced inflammation through the TLR4/MyD88 signaling pathway, suggesting that CRT0066101 may have therapeutic value in acute lung injury and other MyD88-dependent inflammatory diseases. |
format | Online Article Text |
id | pubmed-10181585 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101815852023-05-15 Small molecule inhibitor CRT0066101 inhibits cytokine storm syndrome in a mouse model of lung injury Cui, Bomiao Liu, Yiying Chen, Jiao Chen, Hongli Feng, Yun Zhang, Ping Int Immunopharmacol Article Pneumonia is an acute inflammation of the lungs induced by pathogenic microorganisms, immune damage, physical and chemical factors, and other factors, and the latest outbreak of novel coronavirus pneumonia is also an acute lung injury (ALI) induced by viral infection. However, there are currently no effective treatments for inflammatory cytokine storms in patients with ALI/acute respiratory distress syndrome (ARDS). Protein kinase D (PKD) is a highly active kinase that has been shown to be associated with the production of inflammatory cytokines. Therefore, small-molecule compounds that inhibit PKD may be potential drugs for the treatment of ALI/ARDS. In the present study, we evaluated the ability of the small-molecule inhibitor CRT0066101 to attenuate lipopolysaccharide (LPS)-induced inflammatory cytokine production through in vitro cell experiments and a mouse pneumonia model. We found that CRT0066101 significantly reduced the protein and mRNA levels of LPS-induced cytokines (e.g., IL-6, TNF-α, and IL-1β). CRT0066101 inhibited MyD88 and TLR4 expression and reduced NF-κB, ERK, and JNK phosphorylation. CRT0066101 also reduced NLRP3 activation, inhibited the assembly of the inflammasome complex, and attenuated inflammatory cell infiltration and lung tissue damage. Taken together, our data indicate that CRT0066101 exerts anti-inflammatory effects on LPS-induced inflammation through the TLR4/MyD88 signaling pathway, suggesting that CRT0066101 may have therapeutic value in acute lung injury and other MyD88-dependent inflammatory diseases. Elsevier B.V. 2023-07 2023-05-12 /pmc/articles/PMC10181585/ /pubmed/37182445 http://dx.doi.org/10.1016/j.intimp.2023.110240 Text en © 2023 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Cui, Bomiao Liu, Yiying Chen, Jiao Chen, Hongli Feng, Yun Zhang, Ping Small molecule inhibitor CRT0066101 inhibits cytokine storm syndrome in a mouse model of lung injury |
title | Small molecule inhibitor CRT0066101 inhibits cytokine storm syndrome in a mouse model of lung injury |
title_full | Small molecule inhibitor CRT0066101 inhibits cytokine storm syndrome in a mouse model of lung injury |
title_fullStr | Small molecule inhibitor CRT0066101 inhibits cytokine storm syndrome in a mouse model of lung injury |
title_full_unstemmed | Small molecule inhibitor CRT0066101 inhibits cytokine storm syndrome in a mouse model of lung injury |
title_short | Small molecule inhibitor CRT0066101 inhibits cytokine storm syndrome in a mouse model of lung injury |
title_sort | small molecule inhibitor crt0066101 inhibits cytokine storm syndrome in a mouse model of lung injury |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181585/ https://www.ncbi.nlm.nih.gov/pubmed/37182445 http://dx.doi.org/10.1016/j.intimp.2023.110240 |
work_keys_str_mv | AT cuibomiao smallmoleculeinhibitorcrt0066101inhibitscytokinestormsyndromeinamousemodeloflunginjury AT liuyiying smallmoleculeinhibitorcrt0066101inhibitscytokinestormsyndromeinamousemodeloflunginjury AT chenjiao smallmoleculeinhibitorcrt0066101inhibitscytokinestormsyndromeinamousemodeloflunginjury AT chenhongli smallmoleculeinhibitorcrt0066101inhibitscytokinestormsyndromeinamousemodeloflunginjury AT fengyun smallmoleculeinhibitorcrt0066101inhibitscytokinestormsyndromeinamousemodeloflunginjury AT zhangping smallmoleculeinhibitorcrt0066101inhibitscytokinestormsyndromeinamousemodeloflunginjury |